A story posted by 3news says that "a complaint about a website advertisement for contact lenses wrongly claiming approval by optometrists has been upheld by the New Zealand's Advertising Standards Authority (ASA). L Frederikson of the New Zealand Association of Optometrists (NZAO) complained about claims made by Luxottica Retail NZ on its Contacts2Go website, saying they contained errors in fact and were misleading."

Optometrists in New Zealand objected to the phrase on the home webpage saying "Optometrist Approved" and the body of the ad that stated Contacts2Go has been approved by optometrists.

The story noted that "the ASA said there was a high standard of social responsibility expected in the advertising of therapeutic products and the ad failed to meet those standards, so breached the therapeutic products advertising code."

Posted by ct3/opticalceu at 6:52 AM EDT
Post Comment | Permalink | Share This Post

Who cares? Great Britiain's DailyMirror apparently has little better to do than follow David Beckham, wondering why he was honing and then removing his eyewear.

Here's one from VisionMonday: "The President of the Italian Chamber of Deputies appeared in newspapers and on national TV wearing Pramaor eyewear."

Posted by ct3/opticalceu at 7:46 AM EDT
Updated: Sunday, 12 September 2010 8:03 AM EDT
Post Comment | Permalink | Share This Post

Opticians have become accustomed to an end-of-the-year sales rush--not sparked by the holidays. Customers want to spend the remainder of the flex spending (FSA--flexibile spending accounts). With the passage of the recent health care bill, FSA's will change.

OTC meds and devices will require a doctor's note if the patient wants to apply his/her FSA. There are exceptions, such as contact lens supplies and reading glasses.

By  2013, the law limits FSA allocations to $2500 annually tax-free,  down from the current $5000 tax-free. Apparently individuals in the past would use their left over flex spending to go on buying sprees. Click here for more.

Posted by ct3/opticalceu at 8:05 AM EDT
Post Comment | Permalink | Share This Post

Under considerable pressure from the Federal Trade Commission, Novartis is readying to sell Miochol-E to competitor Bausch & Lomb. Novartis had to csell the drug before the FTC would approve its aquisition of Alcon. Why?  Both companies made the only injectable miotics, which physicians use in cataract surgery.That's the report from Business Week.

Posted by ct3/opticalceu at 7:41 AM EDT
Post Comment | Permalink | Share This Post

This report is from the PRWeb site: "The Food and Drug Administration (FDA) is proving its newly formed concern regarding the safety and validity of claimed 'impact-resistant lenses' in eyeglasses and sunglasses by initiating a new FDA Import Alert, last updated on August 26, 2010. Import Alert 86-07 'Detention Without Physical Examination of and Guidance for 'Impact-Resistant Lenses in Eyeglasses and Sunglasses' (IA 86-07) includes a Red List of five firms which have been added only since July 15, 2010. Three of these five firms were added on August 26, 2010. ... Sunglasses (with or without UV protection) and eyeglasses (prescription and nonprescription) are regulated by FDA as medical devices."

Posted by ct3/opticalceu at 8:56 AM EDT
Updated: Friday, 3 September 2010 3:51 PM EDT
Post Comment | Permalink | Share This Post